Showing results (261-270 of 300) with videos related to

Sort By:
Pageof 30
European Journal of Haematology|July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical RoutineSteffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
Annals of Hematology|July 5, 2024
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)Susanne Isfort, Nikolas von Bubnoff, Haifa Kathrin Al-Ali, et al.
BMC Musculoskeletal Disorders|January 18, 2011
Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animalsRichard T Hinkle, Frank R Lefever, Elizabeth T Dolan, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 13, 2022
SS18-SSX drives CREB activation in synovial sarcomaMagdalene Cyra, Miriam Schulte, Ruth Berthold, et al.
BMC Medicine|July 14, 2007
Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx miceRichard T Hinkle, Frank R Lefever, Elizabeth T Dolan, et al.
Annals of Hematology|June 24, 2016
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physiciansA Kaifie, S Isfort, N Gattermann, et al.
Scientific Reports|May 29, 2013
Skin stem cell hypotheses and long term clone survival--explored using agent-based modellingX Li, A K Upadhyay, A J Bullock, et al.
Annals of the New York Academy of Sciences|October 25, 2019
Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathiesMonica S Ventura Ferreira, Martin Kirschner, Insa Halfmeyer, et al.
Haematologica|August 29, 2015
Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG)Paula Cramer, Susanne Isfort, Jasmin Bahlo, et al.
Pageof 30